Clinical Trials Browser

Completed × Gliosarcoma × depatuxizumab mafodotin × Clear all

NCT02573324 2023-05-11

Intellance1

Phase 3 Completed

691 enrolled 28 charts

Brain Neoplasms, Glioblastoma, Gliosarcoma